FTDR Q1 2026 Earnings EPS Surpasses Estimates with 587 Beat MNRO Q1 2026 Earnings EPS Surpasses Estimates as Cost Management Drives Profitability Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up LKQ Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick BZ Q1 2026 Earnings EPS Beats Estimates Modestly Despite Flat Revenue Disclosure UE Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment